Turney Patricia A. 4
4 · Arcutis Biotherapeutics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Turney Patricia A.
Senior VP, Manufacturing
Transactions
- Sale
Common Stock
2022-03-01$17.75/sh−936$16,617→ 18,836 total
Footnotes (4)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). Shares and RSUs remain subject to a lock-up agreement with the underwriters for the Issuer's follow-on offering in February 2021.
- [F2]The transaction was executed in multiple trades in prices ranging from $17.40 to $18.185, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,001 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as follows: 947 shares on May 31, 2021 and 54 shares on November 30, 2021.
- [F4]Includes 14,000 RSUs.